Healthcare perspectives from The Economist Intelligence Unit



Hero Carousel


Bringing healthcare to hard-hit areas in Bangladesh




Fertility policy and practice: a Toolkit for the Asia-Pacific region

The fertility rates of many countries in the Asia Pacific region (APAC) have been drastically declining over the past 70 years. This has had an impact not only on the population size of these countries, but also on the structure of the population. South Korea has the lowest total fertility rate (TFR) in the world at 0.8, well below the replacement rate of 2.1, and Singapore and Japan are not much higher, at 1.1 and 1.3 respectively. Along with this, the population of older persons (aged over 60) in the region is expected to triple between 2010 and 2050. 

Personalised healthcare for billions: Communication challenges in the post covid-19 age

Personalised healthcare for billions: Communication challenges in the post covid-19 age is a report written by Economist Impact and commissioned by WhatsApp. 

Fact or fiction: Overcoming health misinformation

Covid-19 vaccines do not alter DNA. Nonetheless, the idea is widely shared on social media. It’s simply false and education is needed to battle the notion.

But a frightening and misunderstood instance of rare, potentially fatal blood clots in a handful of cases is harder to combat. There have been links to clotting with certain vaccines and researchers are only beginning to understand why but peer reviews are still pending. Meanwhile, misinformation is still spreading. The public doesn’t wait for answers; they take inaction now.

Podcast | Vaccine diplomacy in Asia

Vaccine diplomacy in Asia

Podcast | Healthcare sustainability

Healthcare sustainability

Into the New World: The Covid-19 Pandemic’s Impact on Innovation

The Covid-19 pandemic is the most significant global disruption since World War II and the first truly global public health crisis in the modern era. Entire industries have ground to a halt; international travel has receded to its lowest level in 75 years; nearly all of the world’s leading economies are in recession; and at the time of publication, more than one million people have died from the virus and its complications. As the pandemic forces profound change in all aspects of society, technology is playing a starring role in enabling organisations to respond to disruption.

Podcast | Vaccine development: A race to the finish line

Vaccine development: A race to the finish line

Racism is a public health issue

Racism is still pernicious, pervasive and cutting short the lives of black Americans to this day.

State of patient centricity 2020: Advancing from patient-first intentions to true co-creation

Patient centricity is a near-universal goal in pharmaceutical research and development, but one without a commonly accepted definition. The challenge now is putting it into practice and understanding its impact on clinical trials. This Economist Intelligence Unit study, sponsored by Medidata, draws on insights from patient advocates, leading pharmaceutical and clinical research industry executives and extensive desk research.

The workplace response to neurological conditions: A focus on migraine, multiple sclerosis and Alzheimer’s disease

Migraine, multiple sclerosis (MS) and Alzheimer’s disease (AD) affect over 1.3bn people globally. The report  looks at the impact of these three neurological conditions on both patients and carers in the workplace.

Enjoy in-depth insights and expert analysis - subscribe to our Perspectives newsletter, delivered every week